PFE's new CEO has done a good job so far. It seems he has a little bit more clarity what he wants PFE to be. PFE getting out of cardiovascular area didn't make any sense to me. Cardiovascular is a big market, and it is big pharma's job.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.